Topic guide
Articles and reference material connected to this topic, organised for clear reading.
Reading path
Health alert Status: Active Date issued: 19 June 2026 Issued by: Dr Caroline McElnay, Chief Health Officer Issued to: Health professionals and the Victorian community Key messages The department has been notif…
Read guide →By A.J. Hostetler More than 85% of obese participants with fatty liver disease in a clinical trial of the experimental drug retatrutide reduced their liver fat to the point where they would no longer be classi…
Read guide →Abstract Mitochondria-derived peptides (MDPs) are bioactive molecules encoded by small open reading frames within mitochondrial DNA (mtDNA). Humanin, the first MDP to be discovered, functions as a cytoprotecti…
Read guide →Researchers at the U of A College of Medicine – Phoenix develop a first-in-class peptide therapy to disrupt a key protein interaction driving liver scarring A promising new therapy developed at the University …
Read guide →Introduction Peptides are short, variable-length amino acid (AA) chains connected by peptide bonds. They are considered as effective AA sources owing to their higher in vivo absorption than AA monomers. These …
Read guide →Key Takeaways Peptides — short chains of amino acids that act as targeted signaling molecules — have shown early promise for reducing liver fat by improving metabolism, lowering inflammation, and reversing fib…
Read guide →Introduction The liver has a high regenerative ability and can induce spontaneous regression of fibrosis when early liver damage occurs resolving chronic liver diseases. However, when chronic liver damage cont…
Read guide →Introduction Non-alcoholic fatty liver disease (NAFLD), recently renamed steatotic liver disease, is a chronic condition characterised by an accumulation of ectopic lipids in the liver parenchyma, accounting f…
Read guide →Fatty liver is a very common disease worldwide (it affects 25-30% of the population) and can have important repercussions on the liver, such as the development of cirrhosis and cancer, and on other organs (car…
Read guide →Abstract PGPIPN is a therapeutic hexapeptide derived from bovine β-casein. Here we investigated the role and mechanism of this peptide on alcoholic fatty liver disease (AFLD). We took human hepatic cell line L…
Read guide →Peptides are smaller versions of proteins. They may provide pro-aging support, anti-inflammatory, or muscle-building properties. However, more research is still necessary to understand their risks and benefits…
Read guide →